Stock Market Securities Research

By admin on December 17, 2018

Securities Research, an independent stock market investment research company offering private investors unbiased information and advice, has a very impressive record of successful investment since 1981.We publish two monthly newsletters, “Market Analysis” and “International Investor”, plus an interactive Online Share Selection database covering all Australian and New Zealand companies:

Company History

Online Share Selectiononline interactive database:

This database covers all Australian and New Zealand listed companies, including data for many valuable share selection techniques that are not available from any other source (e.g. Relative Price Strength ratings, Insider Buying and Selling over the last 52-weeks, Price/Sales ratios, Broker Neglect).
The program and online database provide:(1) Weekly updates of several standard reports from the monthly “Market Analysis” newsletter, and
(2) User-friendly, fully interactive online share selection. Investors can select shares meeting any combination of the different criteria available, with results sorted by any of these criteria.Subscribers can access the latest data, while visitors can test this service with a fully functioning program but have access to only historical data (for December 2002).

This service is currently FREE to “Market Analysis” subscribers!

Our founder, James Cornell, began investing his own money in the stock market in 1971 (at age 12 and starting with just $500).
While a student at Auckland University from 1977-1980 he spent much of his time independently studying all forms of investment – and concluded that the stock market offered investors the best opportunities to build wealth.
In 1981 Securities Research Company was established to continue his research and to provide the independent research and unbiased advice that James needed to manage his own stock market investments.

In March 1981 the “Market Analysis“ newsletter was published to share that work with other private investors. International investments were covered from March 1985, with coverage expanded and transferred to “International Investor“ in January 1996. Australian shares have been covered in “Market Analysis” since February 1994. Our share selection database was established in 1981 and finally made available to other investors via the Internet from January 2003 with the Online Share Selection service.

Extremely Successful Investment Track Record

Over the last 20 years Securities Research Company has built up an extremely impressive track record of successful investment on the NZ and Australian stock markets and internationally.
We aim to analyse the stock market in an intelligent and scientific manner – consistently applying sound investment principles and practice in the search for superior long-term investment returns. We generally avoid the popular, over-valued shares and instead search for out-of-favour, under-valued shares or emerging growth companies that have not yet been “discovered” by stockbrokers and institutional investors.
Check out our FULL track record for “Market Analysis” recommendations (for the 1980’s, the 1990’s and the 2000’s) and “International Investor” recommendations for yourself. No other investment advisor in the world dares to publish their full track record on the internet!

Independent Research and Advice

Securities Research is a completely independent stock market research company. We are not stockbrokers and do not manage other people’s money. All subscribers retain and use their own stockbrokers. All of our revenue comes from newsletter subscriptions. So our advice is always 100% independent and unbiased.

We Put Our Own Money In Every Recommendation

We invest our own money in every share or fund that we recommend in “Market Analysis” and “International Investor”.
James Cornell is now an independently wealthy investor but continues to work full time as Research Director and Editor of our newsletters.

#pennystocks Abeona (NASDAQ:ABEO) Abeona (NASDAQ:ABEO), a quality treatment organization that is in late-stage clinical trial for the treatment of Sanfilippo disorder, an uncommon hereditary condition that causes lethal cerebrum harm. The confusion impacts around 1 in 70,000 kids, an acquired condition which is brought about by a chemical insufficiency. The lack of the compound keeps […]

#pennystocks Abraxas Petroleum (NASDAQ:AXAS) Abraxas Petroleum (NASDAQ:AXAS) issued an overhaul where it talked about a few things including its well performance and execution, resource deals and supporting action. The data shows that Abraxas keeps on decreasing its danger through deleveraging and supporting, while it gives off an impression of being on track to meet its […]

#pennystocks Adamis Pharmaceuticals (ADMP) Shares of Adamis Pharmaceuticals (ADMP) were slipping 16.71% to $2.89 on substantial exchanging volume after adversary drug-producer Mylan (MYL) reported it would dispatch a non specific form of its serious hypersensitivity medicine EpiPen in the up and coming weeks. Adamis, a San Diego-based pharmaceutical organization, is as of now looking for […]

#pennystocks Welcome to Pennystocks.money. We specialize in finding hidden gems in the OTC. We find companies with new and exciting visions and help spotlight these companies. The great thing about Penny stocks is that they give investors the chance to make an enormous return on a small investment. We have had several stocks that we […]

#pennystocks 22nd Century Group (NYSEMKT:XXII) Everything you need to know about XXII stock. 22nd Century Group (NYSEMKT:XXII) is a generally underfollowed organization with a market capitalization of about $60 million, which has constrained it to fly under the radar of financial specialists. In analyst’s assessments, the stock price could increase to $2 in the next […]